Investors & Media

Press Releases

Date Title    
03/30/20
BOSTON , March 30, 2020 /PRNewswire/ --  NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced financial results for
01/13/20
01/10/20